August J. Troendle serves as Executive at Coherus BioSciences, Inc., where they oversee executive responsibilities. Since joining the company, August J. Troendle has executed 283 insider transactions totaling $1.5B, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 30, 2023 involved selling 7,871 shares valued at $2.1M.
August J. Troendle currently holds 646,184 shares of Coherus BioSciences, Inc. (CHRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, August J. Troendle has been a net seller of CHRS stock. They have purchased $174.8M and sold $1.3B worth of shares.
August J. Troendle's most recent insider trade was on Nov 30, 2023, when they sold 7,871 shares at $272.18 per share.
Get notified when new Form 4 filings are submitted
| $272.62 |
| Discretionary |
| Nov 29, 2023 | MEDP | $864.2K | Sale | 3,167 | $272.87 | Discretionary |
| Nov 28, 2023 | MEDP | $6.0M | Sale | 21,833 | $273.66 | Discretionary |
| Nov 27, 2023 | MEDP | $6.9M | Sale | 25,000 | $276.10 | Discretionary |
| Nov 22, 2023 | MEDP | $6.9M | Sale | 25,000 | $277.81 | Discretionary |
| Nov 21, 2023 | MEDP | $6.9M | Sale | 25,000 | $277.37 | Discretionary |
| Nov 20, 2023 | MEDP | $13.8M | Sale | 50,000 | $275.45 | Discretionary |
| Nov 17, 2023 | MEDP | $13.7M | Sale | 50,000 | $273.91 | Discretionary |
| Nov 16, 2023 | MEDP | $4.8M | Sale | 17,000 | $281.61 | Discretionary |
| Nov 15, 2023 | MEDP | $9.4M | Sale | 33,000 | $283.42 | Discretionary |
| Nov 14, 2023 | MEDP | $7.1M | Sale | 25,000 | $283.11 | Discretionary |
| Sep 21, 2023 | MEDP | $15.1M | Sale | 61,655 | $244.27 | Planned |
| Sep 20, 2023 | MEDP | $16.8M | Sale | 65,653 | $255.48 | Planned |
| Sep 19, 2023 | MEDP | $35.7M | Sale | 137,379 | $259.66 | Planned |
| Sep 18, 2023 | MEDP | $14.7M | Sale | 53,385 | $274.76 | Planned |
| Jun 8, 2023 | MEDP | $10.9M | Sale | 49,347 | $220.85 | Planned |
| Jun 7, 2023 | MEDP | $24.6M | Sale | 110,324 | $223.05 | Planned |
| Jun 6, 2023 | MEDP | $12.9M | Sale | 58,681 | $220.46 | Planned |
| Apr 25, 2023 | MEDP | $7.0M | Sale | 31,648 | $221.83 | Planned |
| Sep 22, 2022 | MEDP | $8.9M | Purchase | 57,426 | $154.59 | Discretionary |
| Sep 21, 2022 | MEDP | $15.2M | Purchase | 94,119 | $161.63 | Discretionary |
| Sep 20, 2022 | MEDP | $14.6M | Purchase | 94,119 | $155.14 | Discretionary |
| Sep 19, 2022 | MEDP | $14.4M | Purchase | 94,119 | $153.48 | Discretionary |
| Sep 16, 2022 | MEDP | $9.4M | Purchase | 62,516 | $149.58 | Discretionary |
| Sep 15, 2022 | MEDP | $9.6M | Purchase | 62,516 | $153.11 | Discretionary |
| Sep 14, 2022 | MEDP | $9.5M | Purchase | 62,516 | $152.66 | Discretionary |
| Sep 13, 2022 | MEDP | $9.8M | Purchase | 62,516 | $157.12 | Discretionary |
| Sep 12, 2022 | MEDP | $10.5M | Purchase | 62,515 | $167.58 | Discretionary |
| Sep 9, 2022 | MEDP | $9.3M | Purchase | 56,557 | $164.33 | Discretionary |